First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States.
Article Details
- CitationCopy to clipboard
Lolans K, Queenan AM, Bush K, Sahud A, Quinn JP
First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States.
Antimicrob Agents Chemother. 2005 Aug;49(8):3538-40.
- PubMed ID
- 16048978 [ View in PubMed]
- Abstract
Carbapenemases are rare in the United States. This is the first report of a United States nosocomial outbreak of pan-resistant Pseudomonas aeruginosa infections due to an integron-borne metallo-beta-lactamase, VIM-2. This emergence of carbapenemases on mobile genetic elements in the United States warrants surveillance.